North America Digital Genome Market 2021-2028

MARKET OUTLOOK

As per this report, the North America market for digital genome is expected to rise with a CAGR of 9.75% in the estimated years from 2021 to 2028. The United States and Canada together shape the market in this region.
The United States dominates North America’s genome editing market. The high rate of adoption of advanced technology, the presence of big industry names, high funds for genomic research are all factors attributable to the major share of the country in this market.

Further, extensive research activities in genomics, gene editing, cell line culture, and modification are being conducted, which is boosting the market growth in the US. Several globally-renowned manufacturers of DNA sequencing technologies, equipment, and platforms are active in the US.

For instance, several prominent names in the DNA sequencing industry, such as Thermo Fisher Scientific, Illumina, and others have their corporate presence in the nation, and the enhanced adoption of DNA sequencing has led to a rise in the creation of genomic databases like Ensembl Human Genome Server, UCSC Human Genome Browser Gateway, and others. These factors are projected to drive the digital genome market in the US.

In addition, factors like growing awareness of DNA sequencing, and its applications in different fields, including personalized medicine, clinical diseases, agri-genomics, and others, are contributing to market progress.

COMPETITIVE OUTLOOK

Some of the companies present in this market include Oxford Nanopore Technologies Ltd, Inscripta, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company (BD), Pacific Bioscience, and Abbott Laboratories.

1. North America Digital Genome Market - Summary

2. Industry Outlook

2.1. Porter's Five Forces Model
2.1.1. Threat of New Entrants
2.1.2. Threat of Substitute Products
2.1.3. Bargaining Power of Buyers
2.1.4. Bargaining Power of Suppliers
2.1.5. Competitive Rivalry
2.2. Impact of Covid-19 on Digital Genome Market
2.3. Market Attractiveness Index
2.4. Vendor Landscape
2.5. Key Insights
2.6. Key Drivers
2.6.1. Proliferating Burden of Chronic Diseases
2.6.2. Continuous Funding by the Manufacturers and Government in the Field of Genomics
2.7. Key Restraints
2.7.1. Security Risks Associated With Digital Genome
2.7.2. Lack of Skilled Professionals in the Field of Genome Technology
2.8. Key Opportunities
2.8.1. Technological Advancements
2.8.2. Prevailing Awareness in the Developing Economies Regarding Dna Sequencing Technologies

3. Digital Genome Market Outlook - by Product

3.1. Sequencing and Analyzer Instruments
3.2. Dna/Rna Analysis
3.3. Sequencing and Analysis Software
3.4. Sequencing Chips
3.5. Sample Prep Instruments

4. Digital Genome Market Outlook - by Application

4.1. Diagnostics
4.2. Drug Discovery
4.3. Academic Research
4.4. Personalized Medicine
4.5. Agricultural
4.6. Other Applications

5. Digital Genome Market Outlook - by End-User

5.1. Diagnostics and Forensic Labs
5.2. Academic Research Institutes
5.3. Hospitals
5.4. Other End-Users

6. Digital Genome Market - North America

6.1. Country Analysis
6.1.1. The United States
6.1.2. Canada

7. Company Profile

7.1. Qiagen Nv
7.2. Oxford Nanopore Technologies Ltd
7.3. Becton, Dickinson, and Company (Bd)
7.4. Illumina Inc
7.5. Thermo Fisher Scientific Inc
7.6. Pacific Bioscience
7.7. Bio-Rad Laboratories Inc
7.8. F. Hoffmann-La Roche
7.9. Perkinelmer Inc
7.10. Regeneron Pharmaceuticals
7.11. Biomerieux Sa
7.12. Abbott Laboratories
7.13. Agilent Technologies Inc.
7.14. Inscripta

8. Research Methodology & Scope

8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis

List of Tables

Table 1: North America Digital Genome Market, by Country, 2021-2028 (In $ Million)
Table 2: Vendor Landscape
Table 3: North America Digital Genome Market, by Product, 2021-2028 (In $ Million)
Table 4: North America Digital Genome Market, by Application, 2021-2028 (In $ Million)
Table 5: North America Digital Genome Market, by End-User, 2021-2028 (In $ Million)
Table 6: North America Digital Genome Market, by Country, 2021-2028 (In $ Million)

List of Figures

Figure 1: North America Digital Genome Market, 2021-2028 (In $ Million)
Figure 2: North America Digital Genome Market, by Sequencing and Analyzer Instruments, 2021-2028 (In $ Million)
Figure 3: North America Digital Genome Market, by Dna/Rna Analysis, 2021-2028 (In $ Million)
Figure 4: North America Digital Genome Market, by Sequencing and Analysis Software, 2021-2028 (In $ Million)
Figure 5: North America Digital Genome Market, by Sequencing Chips, 2021-2028 (In $ Million)
Figure 6: North America Digital Genome Market, by Sample Prep Instruments, 2021-2028 (In $ Million)
Figure 7: North America Digital Genome Market, by Diagnostics, 2021-2028 (In $ Million)
Figure 8: North America Digital Genome Market, by Drug Discovery, 2021-2028 (In $ Million)
Figure 9: North America Digital Genome Market, by Academic Research, 2021-2028 (In $ Million)
Figure 10: North America Digital Genome Market, by Personalized Medicine, 2021-2028 (In $ Million)
Figure 11: North America Digital Genome Market, by Agricultural, 2021-2028 (In $ Million)
Figure 12: North America Digital Genome Market, by Other Applications, 2021-2028 (In $ Million)
Figure 13: North America Digital Genome Market, by Diagnostics and Forensic Labs, 2021-2028 (In $ Million)
Figure 14: North America Digital Genome Market, by Academic Research Institutes, 2021-2028 (In $ Million)
Figure 15: North America Digital Genome Market, by Hospitals, 2021-2028 (In $ Million)
Figure 16: North America Digital Genome Market, by Other End-Users, 2021-2028 (In $ Million)
Figure 17: North America Digital Genome Market, 2021-2028 (In $ Million)
Figure 18: the United States Digital Genome Market, 2021-2028 (In $ Million)
Figure 19: Canada Digital Genome Market, 2021-2028 (In $ Million)